217 related articles for article (PubMed ID: 33636352)
1. Features and development trends in international standardization of Chinese materia medica in ISO/TC 249.
Xu XT; Shi YH; Sang Z; Zhou H
Pharmacol Res; 2021 May; 167():105519. PubMed ID: 33636352
[TBL] [Abstract][Full Text] [Related]
2. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.
Shi YH; Huang YF; Wang WY; Yang L; Zhou H; Sang Z
Pharmacol Res; 2020 Oct; 160():105074. PubMed ID: 32653649
[TBL] [Abstract][Full Text] [Related]
3. [Current status and development strategy of ISO/TC 249 standards for Chinese materia medica].
He YL; Guo LP; Ge Y; Tan Y; Kang CZ; Xu XT; Lyu CG; Yang LH; Yuan QJ
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3675-3680. PubMed ID: 35850822
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Comparison Analysis of WHO Monographs on Selected Medicinal Plants and ISO Standards of Chinese Materia Medica.
Yang JY; Sang Z; Wang R; Shi YH; Huang YR
Chin J Integr Med; 2023 Jun; 29(6):540-548. PubMed ID: 35508858
[TBL] [Abstract][Full Text] [Related]
5. The current global status of Chinese materia medica.
Liu X; Zou J; Sheng Z; Su G; Chen S
Phytother Res; 2009 Oct; 23(10):1493-5. PubMed ID: 19787664
[TBL] [Abstract][Full Text] [Related]
6. The Integration of Chinese Material Medica into the Chinese Health Care Delivery System, an Update.
Dang H; Wang Q; Wang H; Yan M; Liu X
Phytother Res; 2016 Feb; 30(2):292-7. PubMed ID: 26728426
[TBL] [Abstract][Full Text] [Related]
7. A unique issue in the standardization of Chinese materia medica: processing.
Zhao Z; Liang Z; Chan K; Lu G; Lee EL; Chen H; Li L
Planta Med; 2010 Dec; 76(17):1975-86. PubMed ID: 21049396
[TBL] [Abstract][Full Text] [Related]
8. [Status and suggestions for adjuvant standard for Chinese materia medica processing in China].
Yang CY; Cao H; Wang XT; Tu JS; Qian ZZ; Yu ZL; Shang Y; Zhang BX
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(7):1401-1406. PubMed ID: 29052406
[TBL] [Abstract][Full Text] [Related]
9. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.
Williamson EM; Lorenc A; Booker A; Robinson N
J Ethnopharmacol; 2013 Sep; 149(2):453-62. PubMed ID: 23832055
[TBL] [Abstract][Full Text] [Related]
10. [Strategies for efficacy and function positioning of new resources of Chinese materia medica].
Li ZY; Wang JQ; Li CF; Zhang XB; Yang HJ; Huang LQ; Yang B
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3455-3464. PubMed ID: 34402267
[TBL] [Abstract][Full Text] [Related]
11. [Good agricultural practice (GAP) of Chinese materia medica (CMM) for ten years: achievements, problems and proposals].
Guo LP; Zhang Y; Zhu SD; Wang GH; Wang X; Zhang XB; Chen ML; He YL; Han BX; Chen NF; Huang LQ
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1143-51. PubMed ID: 25011244
[TBL] [Abstract][Full Text] [Related]
12. ISO/TC 249 platform promotes the development of international standardization and trade for the Chinese medicines industry.
Huang YF; He F; Xie Y; Liu L; Zhou H
Pharmacol Res; 2020 Oct; 160():105066. PubMed ID: 32650056
[TBL] [Abstract][Full Text] [Related]
13. [Survey of investigations on Daodi Chinese medicinal materials in China since 1980s].
Xiao X; Chen S; Huang L; Xiao P
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):519-23. PubMed ID: 19526774
[TBL] [Abstract][Full Text] [Related]
14. [Research model on commodity specification standard of radix Chinese materia medica].
Kang CZ; Zhou T; Jiang WK; Huang LQ; Guo LP
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):769-775. PubMed ID: 28875626
[TBL] [Abstract][Full Text] [Related]
15. [Current standards for seeds and seedlings of Chinese materia medica and analysis].
Yao X; Cao HL
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):745-756. PubMed ID: 33645043
[TBL] [Abstract][Full Text] [Related]
16. [Bio-characteristic profiling related to clinic:thought and practice on quality evaluation of Chinese materia medica].
Yan D
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(3):409-414. PubMed ID: 30989901
[TBL] [Abstract][Full Text] [Related]
17. Considerations for the Quality Control of Newly Registered Traditional Chinese Medicine in China: A Review.
Qu J; Zhang T; Liu J; Su Y; Wang H
J AOAC Int; 2019 May; 102(3):689-694. PubMed ID: 30381092
[No Abstract] [Full Text] [Related]
18. [Investigation on pattern of quality control for Chinese materia medica based on famous-region drug and bioassay--the work reference].
Yan D; Xiao X
Zhongguo Zhong Yao Za Zhi; 2011 May; 36(9):1249-52. PubMed ID: 21842660
[TBL] [Abstract][Full Text] [Related]
19. [Formation and evolution of commodity specification and grade of traditional Chinese medicine].
Li PY; Wang HY; Li J; Zhan ZL; Yang G
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):764-768. PubMed ID: 28875625
[TBL] [Abstract][Full Text] [Related]
20. [Research progress on standards of commodity classes of Chinese materia medica and discussion on several key problems].
Yang G; Zeng Y; Guo LP; Huang LQ; Jin Y; Zheng YG; Wang YY
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1733-8. PubMed ID: 25095394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
